Harry Suryapranata, MD, PhD

Coronary Intervention with a Heparin-Coated Stent and <br />
Aspirin Only<br />

08/01/2008

Harry Suryapranata , MD, PhD;

Kui-Hian Sim ;

Otte J. Rachman ;

Jeffrey D. Adipranoto ;

Hanafi B. Trisnohadi ;

Nik Ahmad ;

Koon-How Mak ;

James T. Stewart , MD;

Charles N. S. Chan , MBBS;

Muhammad Yusak ;

Peter N. Ruygrok , MD, MB, FRACP, FESC;

Iwan Boestan ;

Teguh Santoso ;

The use of the antiplatelet agents ticlopidine and clopidogrel, in addition to aspirin, has been proven to reduce subacute stent thrombosis (SAT) rates to

The use of the antiplatelet...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Efficacy and Safety of Rapamycin as Compared to Paclitaxel-Eluting Stents: A Meta-Analysis

07/06/2010

Yahya B. Juwana , MD;

Saman Rasoul , MD, PhD;

Jan Paul Ottervanger , MD, PhD;

Harry Suryapranata , MD, PhD;

ABSTRACT: Objective. To compare the efficacy of rapamycin-eluting stents (RES) and paclitaxel-eluting stents (PES) in patients undergo percutaneous coronary intervention. Background. RES and PES differ significantly with respect to polymer...

ABSTRACT: Objective. To...

07/06/2010

Journal of Invasive Cardiology

Original Contribution

Closure Device or Manual Compression in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Comparison

12/21/2010

Jan Paul Ottervanger , MD, PhD;

Harry Suryapranata , MD, PhD;

Arnoud W.J. van't Hof , MD, PhD;

Renicus S. Hermanides , MD;

A.T. Marcel Gosselink , MD, PhD;

Jan-Henk E. Dambrink , MD, PhD;

Menko Jan de Boer , MD, PhD;

Jan C.A. Hoorntje , MD, PhD;

Aims. Although closure devices may be comfortable for patients, the clinical benefits in patients with moderate-to-high risk of bleeding are not yet clear. We compared a closure device with manual compression in moderate- to high-risk...

Aims. Although closure devices...

12/21/2010

Journal of Invasive Cardiology